Integrative genomic analysis of N6-methyladenosine-single nucleotide polymorphisms (m⁶A-SNPs) associated with breast cancer

References

• Mattiuzzi C, Lippi G. Current cancer epidemiology. J Epidemiol Glob Health. 2019;9:217–222.
   PubMed Web of Science ®Google Scholar
• Fahad Ullah M. Breast cancer: current perspectives on the disease status. Adv Exp Med Biol. 2019;1152:51–64.
   PubMed Web of Science ®Google Scholar
• Nones K, Johnson J, Newell F, et al. Whole-genome sequencing reveals clinically relevant insights into the aetiology of familial breast cancers. Ann Oncol. 2019;30:1071–1079.
   PubMed Web of Science ®Google Scholar
• Ferreira MA, Gamazon ER, Al-Ejeh F, et al. Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer. Nat Commun. 2019;10:1741.
   PubMed Web of Science ®Google Scholar
• Shiovitz S, Korde LA. Genetics of breast cancer: a topic in evolution. Ann Oncol. 2015;26:1291–1299.
   PubMed Web of Science ®Google Scholar
• Barrdahl M, Canzian F, Lindström S, et al. Association of breast cancer risk loci with breast cancer survival. Int J Cancer. 2015;137:2837–2845.
   PubMed Web of Science ®Google Scholar
• Hamdi Y, Ben Rekaya M, Jingxuan S, et al. A genome wide SNP genotyping study in the Tunisian population: specific reporting on a subset of common breast cancer risk loci. BMC Cancer. 2018;18:1295.
   PubMed Web of Science ®Google Scholar
• Chen M, Wong CM. The emerging roles of N6-methyladenosine (m6A) deregulation in liver carcinogenesis. Mol Cancer. 2020;19:44.
   PubMed Web of Science ®Google Scholar
• Dai D, Wang H, Zhu L, et al. N6-methyladenosine links RNA metabolism to cancer progression. Cell Death Dis. 2018;9:124.
   PubMed Web of Science ®Google Scholar
• Anderson SJ, Kramer MC, Gosai SJ, et al. N(6)-methyladenosine inhibits local ribonucleolytic cleavage to stabilize mRNAs in arabidopsis. Cell Rep. 2018;25:1146–57.e3.
   PubMed Web of Science ®Google Scholar
• Liu J, Sun G, Pan S, et al. The Cancer Genome Atlas (TCGA) based m(6)A methylation-related genes predict prognosis in hepatocellular carcinoma. Bioengineered. 2020;11:759–768.
   PubMed Web of Science ®Google Scholar
• Cai X, Wang X, Cao C, et al. HBXIP-elevated methyltransferase METTL3 promotes the progression of breast cancer via inhibiting tumor suppressor let-7g. Cancer Lett. 2018;415:11–19.
   PubMed Web of Science ®Google Scholar
• Niu Y, Lin Z, Wan A, et al. RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3. Mol Cancer. 2019;18:46.
   PubMed Web of Science ®Google Scholar
• Chen K, Song B, Tang Y, et al. RMDisease: a database of genetic variants that affect RNA modifications, with implications for epitranscriptome pathogenesis. Nucleic Acids Res. 2021;49(D1):D1396–D1404
   PubMed Web of Science ®Google Scholar
• Liu H, Gu J, Jin Y, et al. Genetic variants in N6-methyladenosine are associated with bladder cancer risk in the Chinese population. Arch Toxicol. 2021;95(1):299–309
   PubMed Web of Science ®Google Scholar
• Yang N, Ying P, Tian J, et al. Genetic variants in m6A modification genes are associated with esophageal squamous-cell carcinoma in the Chinese population. Carcinogenesis. 2020;41:761–768.
   PubMed Web of Science ®Google Scholar
• Zhuo Z, Lu H, Zhu J, et al. METTL14 gene polymorphisms confer neuroblastoma susceptibility: an eight-center case-control study. Mol Ther Nucleic Acids. 2020;22:17–26.
   PubMedGoogle Scholar
• Zhuo ZJ, Hua RX, Chen Z, et al. WTAP gene variants confer hepatoblastoma susceptibility: a seven-center case-control study. Mol Ther Oncolytics. 2020;18:118–125.
   PubMed Web of Science ®Google Scholar
• Ren H, Zhuo ZJ, Duan F, et al. ALKBH5 gene polymorphisms and hepatoblastoma susceptibility in chinese children. J Oncol. 2021;2021:6658480.
   PubMed Web of Science ®Google Scholar
• He J, Yuan L, Lin H, et al. Genetic variants in m(6)A modification core genes are associated with glioma risk in Chinese children. Mol Ther Oncolytics. 2021;20:199–208.
   PubMed Web of Science ®Google Scholar
• Hua RX, Liu J, Fu W, et al. ALKBH5 gene polymorphisms and Wilms tumor risk in Chinese children: a five-center case-control study. J Clin Lab Anal. 2020;34:e23251.
   PubMed Web of Science ®Google Scholar
• Ma L, Hua RX, Lin H, et al. The contribution of WTAP gene variants to Wilms tumor susceptibility. Gene. 2020;754:144839.
   PubMed Web of Science ®Google Scholar
• Bian J, Zhuo Z, Zhu J, et al. Association between METTL3 gene polymorphisms and neuroblastoma susceptibility: a nine-centre case-control study. J Cell Mol Med. 2020;24:9280–9286.
   PubMed Web of Science ®Google Scholar
• Zheng Y, Nie P, Peng D, et al. m6AVar: a database of functional variants involved in m6A modification. Nucleic Acids Res. 2018;46:D139–d45.
   PubMed Web of Science ®Google Scholar
• Luo X, Li H, Liang J, et al. RMVar: an updated database of functional variants involved in RNA modifications. Nucleic Acids Res. 2021; 49(D1):D1405–D1412
   PubMed Web of Science ®Google Scholar
• Ward LD, Kellis M. HaploReg v4: systematic mining of putative causal variants, cell types, regulators and target genes for human complex traits and disease. Nucleic Acids Res. 2016;44:D877–81.
   PubMed Web of Science ®Google Scholar
• Ward LD, Kellis M. HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants. Nucleic Acids Res. 2012;40:D930–4.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Zhou B, Pache L, et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 2019;10:1523.
   PubMed Web of Science ®Google Scholar
• Zhu X, Tao L, Yao J, et al. Identification of collaboration patterns of dysfunctional pathways in breast cancer. Int J Clin Exp Pathol. 2014;7:3853–3864.
   PubMed Web of Science ®Google Scholar
• Pau NIB, Zakaria Z, Muhammad R, et al. Gene expression patterns distinguish breast carcinomas from normal breast tissues: the Malaysian context. Pathol Res Pract. 2010;206:223–228.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Zeng P, Li YH, et al. SRAMP: prediction of mammalian N6-methyladenosine (m6A) sites based on sequence-derived features. Nucleic Acids Res. 2016;44:e91.
   PubMed Web of Science ®Google Scholar
• Lin W, Xu H, Wu Y, et al. In silico genome-wide identification of m6A-associated SNPs as potential functional variants for periodontitis. J Cell Physiol. 2020;235:900–908.
   PubMed Web of Science ®Google Scholar
• Mo X, Lei S, Zhang Y, et al. Genome-wide enrichment of m(6)A-associated single-nucleotide polymorphisms in the lipid loci. Pharmacogenomics J. 2019;19:347–357.
   PubMed Web of Science ®Google Scholar
• Chevalier C, Collin G, Descamps S, et al. TOM1L1 drives membrane delivery of MT1-MMP to promote ERBB2-induced breast cancer cell invasion. Nat Commun. 2016;7:10765.
   PubMed Web of Science ®Google Scholar
• Chevalier C, Roche S, Bénistant C. Vesicular trafficking regulators are new players in breast cancer progression: role of TOM1L1 in ERBB2-dependent invasion. Mol Cell Oncol. 2016;3:e1182241.
   PubMed Web of Science ®Google Scholar
• Martínez-Hernández A, Gutierrez-Malacatt H, Carrillo-Sánchez K, et al. Small MAF genes variants and chronic myeloid leukemia. Eur J Haematol. 2014;92:35–41.
   PubMed Web of Science ®Google Scholar
• Su R, Ma J, Zheng J, et al. PABPC1-induced stabilization of BDNF-AS inhibits malignant progression of glioblastoma cells through STAU1-mediated decay. Cell Death Dis. 2020;11:81.
   PubMed Web of Science ®Google Scholar
• Zhang H, Sheng C, Yin Y, et al. PABPC1 interacts with AGO2 and is responsible for the microRNA mediated gene silencing in high grade hepatocellular carcinoma. Cancer Lett. 2015;367:49–57.
   PubMed Web of Science ®Google Scholar
• Dong H, Wang W, Mo S, et al. Long non-coding RNA SNHG14 induces trastuzumab resistance of breast cancer via regulating PABPC1 expression through H3K27 acetylation. J Cell Mol Med. 2018;22:4935–4947.
   PubMed Web of Science ®Google Scholar